Similar articles

• Measurement of serum PSA as a predictor of symptoms scored on the IPSS for patients with benign prostatic hyperplasia.

  Lim CF, Buchan NC. Lim CF, et al. N Z Med J. 2014 Feb 14;127(1389):17-24. N Z Med J. 2014. PMID: 24548953
• Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.

  Saidi S, Stavridis S, Stankov O, Dohcev S, Panov S. Saidi S, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Sep 1;38(2):123-129. doi: 10.1515/prilozi-2017-0030. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017. PMID: 28991765
• Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients.

  Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira AG. Pisco JM, et al. J Vasc Interv Radiol. 2016 Aug;27(8):1115-22. doi: 10.1016/j.jvir.2016.04.001. Epub 2016 Jun 16. J Vasc Interv Radiol. 2016. PMID: 27321890
• Prostate-specific antigen and other prostate cancer markers.

  Stenman U, Finne P, Zhang W, Leinonen J. Stenman U, et al. Urology. 2000 Dec 20;56(6):893-8. doi: 10.1016/s0090-4295(00)00812-8. Urology. 2000. PMID: 11113726 Review. No abstract available.
• Benign prostatic hyperplasia: a progressive disease of aging men.

  Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC. Emberton M, et al. Urology. 2003 Feb;61(2):267-73. doi: 10.1016/s0090-4295(02)02371-3. Urology. 2003. PMID: 12597928 Review. No abstract available.